EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Automated Machine Learning and Explainable AI (AutoML-XAI) for Metabolomics: Improving Cancer Diagnostics

Olatomiwa O Bifarin iD, Facundo M Fernández

Journal of the American Society for Mass Spectrometry · 05.06.2024 · 35 (6) · 1089-1100

DOI: 10.1021/jasms.3c00403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society for Mass Spectrometry, online erschienen am 01.05.2024. Verfasst von Olatomiwa O Bifarin und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States. Hauptthemen laut MEDLINE: Metabolomics, Machine Learning, Ovarian Neoplasms, Kidney Neoplasms. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolomics generates complex data necessitating advanced computational methods for generating biological insight. While machine learning (ML) is promising, the challenges of selecting the best algorithms and tuning hyperparameters, particularly for nonexperts, remain. Automated machine learning (AutoML) can streamline this process; however, the issue of interpretability could persist. This research introduces a unified pipeline that combines AutoML with explainable AI (XAI) techniques to optimize metabolomics analysis. We tested our approach on two data sets: renal cell carcinoma (RCC) urine metabolomics and ovarian cancer (OC) serum metabolomics. AutoML, using Auto-sklearn, surpassed standalone ML algorithms like SVM and k-Nearest Neighbors in differentiating between RCC and healthy controls, as well as OC patients and those with other gynecological cancers. The effectiveness of Auto-sklearn is highlighted by its AUC scores of 0.97 for RCC and 0.85 for OC, obtained from the unseen test sets. Importantly, on most of the metrics considered, Auto-sklearn demonstrated a better classification performance, leveraging a mix of algorithms and ensemble techniques. Shapley Additive Explanations (SHAP) provided a global ranking of feature importance, identifying dibutylamine and ganglioside GM(d34:1) as the top discriminative metabolites for RCC and OC, respectively. Waterfall plots offered local explanations by illustrating the influence of each metabolite on individual predictions. Dependence plots spotlighted metabolite interactions, such as the connection between hippuric acid and one of its derivatives in RCC, and between GM3(d34:1) and GM3(18:1_16:0) in OC, hinting at potential mechanistic relationships. Through decision plots, a detailed error analysis was conducted, contrasting feature importance for correctly versus incorrectly classified samples. In essence, our pipeline emphasizes the importance of harmonizing AutoML and XAI, facilitating both simplified ML application and improved interpretability in metabolomics data science.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetabolomicsMachine LearningOvarian NeoplasmsKidney NeoplasmsHumansFemaleAlgorithmsCarcinoma, Renal CellBiomarkers, Tumor

Stichwörter der Autor:innen

Shapley additive explanationsautomated machine learningcancer biologyexplainable AImetabolomics

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
  • Petit Institute of Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.

ORCID-Profile: Olatomiwa O Bifarin

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Bifarin, O. O., & Fernández, F. M. (2024). Automated Machine Learning and Explainable AI (AutoML-XAI) for Metabolomics: Improving Cancer Diagnostics. Journal of the American Society for Mass Spectrometry, 35(6), 1089-1100. https://doi.org/10.1021/jasms.3c00403

Vancouver

Bifarin OO, Fernández FM. Automated Machine Learning and Explainable AI (AutoML-XAI) for Metabolomics: Improving Cancer Diagnostics. Journal of the American Society for Mass Spectrometry. 2024;35(6):1089-1100. doi:10.1021/jasms.3c00403

BibTeX
@article{Bifarin2024,
  author = {Bifarin, Olatomiwa O and Fernández, Facundo M},
  title = {Automated Machine Learning and Explainable AI (AutoML-XAI) for Metabolomics: Improving Cancer Diagnostics},
  journal = {Journal of the American Society for Mass Spectrometry},
  year = {2024},
  volume = {35},
  number = {6},
  pages = {1089--1100},
  doi = {10.1021/jasms.3c00403}
}
Kostenlos starten →